Evidence map›Paper›PMID 30042823›Full record

ArticleOncotarget2018

Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma.

Georgi Atanasov, Corinna Dietel, Linda Feldbrügge, Christian Benzing, Felix Krenzien, Andreas Brandl, Shadi Katou, Katrin Schierle, Simon C Robson, Katrin Splith and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Modulation of the Receptor Tyrosine Kinase TIE2/International journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. MiR-582 Down-Regulates Lissencephaly-1 (Iranian journal of biotechnology · 2022
    Article
  7. Review
  8. Underexpression of miR-126-3p in Patients with Cholangiocarcinoma.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Georgi AtanasovDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Corinna DietelDepartment of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
Linda FeldbrüggeDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Christian BenzingDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Felix KrenzienDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Andreas BrandlDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Shadi KatouDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Katrin SchierleInstitute of Pathology, University Hospital Leipzig, Leipzig, Germany.
Simon C RobsonThe Transplant Institute and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA.
Katrin SplithDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Georg WiltbergerDepartment of General, Visceral and Transplantation Surgery, University Hospital of RWTH Aachen, Aachen, Germany.
Anja Reutzel-SelkeDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sven JonasDepartment of General and Visceral Surgery, 310Klinik Nürnberg, Nürnberg, Germany.
Andreas PascherDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Marcus BahraDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Johann PratschkeDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Moritz SchmelzleDepartment of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEUniversity Hospital Leipzig · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEBeth Israel Deaconess Medical Center · USNuremberg Hospital · DERWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTumour angiogenesis is modulated on both an epigenetic and protein level and has potential implications for immune cell responses. However, the importance of related angiogenic biomarkers in cholangiocarcinoma (CCA) is unknown. This study assessed human CCA samples for the expression of angiogenesis-associated microRNAs, angiopoietins (Angs) and monocytes expressing the Ang-receptor, TIE2, with regards to prognostic significance after liver resection.

methodsAngiogenic miRNAs were analysed in frozen samples of intrahepatic CCA (iCC; n = 43) and hilar CCA (HC; n = 45). Ang-1 and Ang-2, as well as TIE2-expressing monocytes (TEMs), were detected in paraffin-embedded iCC sections (n = 88). MiRNA expression and the abundance of TEMs and Angs were correlated with clinicopathological characteristics and survival.

resultsMiR-126 was downregulated in 76.7% of all CCA samples, with high relative expression associated with smaller tumours and reduced lymph node metastasis. High Ang-1 expression was associated with less lymphangiosis carcinomatosa and better histological grading (all p < 0.05). The absence of TEMs in iCC correlated with elevated CA19-9 levels. High relative miR-126 and low miR-128 levels were associated with improved survival in iCC and HC, respectively (all p < 0.05). High miR-126, low miR-128 and TEMs were independent prognostic factors for recurrence-free and overall survival (all p < 0.05).

conclusionsThese results suggest that angiogenic miRNAs, Angs and TEMs are of prognostic value in CCA. In addition to the possible functional links between angiogenic miRNA expression profiles, Angs and immune-cell responses by TEMs, these data have clinical implications as novel diagnostic tools.

Indexed as

angiopoietinscholangiocarcinomamicroRNAsmiR-126TIE2-expressing monocytes

Identifiers

PMID30042823
PMCPMC6057457
OpenAlexW2880394956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.